Latest SEC filings for Gilead Sciences, Inc. (GILD) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
Dickinson Andrew D, listed as Chief Financial Officer at GILEAD SCIENCES, INC., reported an open-market sale of 3,000 GILD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Mercier Johanna, listed as Chief Comm & Corp Aff Officer at GILEAD SCIENCES, INC., reported an open-market sale of 3,000 GILD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
JOHANNA MERCIER filed a Form 144 with the SEC indicating intent to sell GILD (GILEAD SCIENCES, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
ANDREW DICKINSON filed a Form 144 with the SEC indicating intent to sell GILD (GILEAD SCIENCES, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
O'Day Daniel Patrick, listed as Director, Chairman & CEO at GILEAD SCIENCES, INC., reported an open-market sale of 10,000 GILD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
DANIEL O'DAY filed a Form 144 with the SEC indicating intent to sell GILD (GILEAD SCIENCES, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
Mercier Johanna, listed as Chief Comm & Corp Aff Officer at GILEAD SCIENCES, INC., reported an open-market sale of 3,000 GILD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Dickinson Andrew D, listed as Chief Financial Officer at GILEAD SCIENCES, INC., reported an open-market sale of 3,000 GILD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
JOHANNA MERCIER filed a Form 144 with the SEC indicating intent to sell GILD (GILEAD SCIENCES, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
ANDREW DICKINSON filed a Form 144 with the SEC indicating intent to sell GILD (GILEAD SCIENCES, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
Dickinson Andrew D (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Mercier Johanna (Chief Comm & Corp Aff Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Cain Wettan Keeley M (EVP Gen Counsel, Legal & Comp) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Burkhart Erin (SVP, Controllership) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
O'Day Daniel Patrick (Director, Chairman & CEO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.